Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Cash Flow Reinvestment Rate
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Cash Flow Reinvestment Rate of 0.09x as of September 2025, reinvesting CN¥63.68 Million (capex CN¥63.68 Million ) from operating cash flow of CN¥670.83 Million. See Shanghai Allist Pharmaceuticals Co. Ltd. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Allist Pharmaceuticals Co. Ltd. A Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Shanghai Allist Pharmaceuticals Co. Ltd. A across 6 annual periods. For the full cash flow conversion analysis, see Shanghai Allist Pharmaceuticals Co. Ltd. (688578) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2025)
Year-by-year capital reinvestment analysis for Shanghai Allist Pharmaceuticals Co. Ltd. A. See financial agility of Shanghai Allist Pharmaceuticals Co. Ltd. to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | CN¥278.90 Million | CN¥2.32 Billion | CN¥186.00 Million | ▼ -45.5% |
| 2024 | 0.22x | CN¥345.07 Million | CN¥1.57 Billion | CN¥270.22 Million | ▼ -7.5% |
| 2023 | 0.24x | CN¥160.63 Million | CN¥674.65 Million | CN¥67.88 Million | ▼ -96.0% |
| 2022 | 5.98x | CN¥548.05 Million | CN¥91.63 Million | CN¥143.83 Million | ▼ -59.4% |
| 2021 | 14.73x | CN¥431.43 Million | CN¥29.29 Million | CN¥192.25 Million | ▲ +10574.3% |
| 2017 | 0.14x | CN¥1.40 Million | CN¥10.11 Million | CN¥1.40 Million | — |